These findings suggest that, in this tumorigenic context of BrafV600E/Pten cKO, the tissue or cellular compartment of origin plays a dominant role in determining tumor phenotype, even when pro-melanoma signaling pathways are activated. The gene discussed is PTEN; the disease is neoplasm.